The following discussion contains forward-looking statements that involve risks
and uncertainties. The following discussion of our financial condition and
results of operations should be read in conjunction with our consolidated
financial statements and the related notes and other financial information
included elsewhere in this Annual Report on Form 10-K. Our actual results may
differ materially from those discussed in the forward-looking statements as a
result of various factors, including those set forth in Part I, Item 1A. "Risk
Factors" and other sections of this Annual Report on Form 10-K. The financial
data discussed below reflects the historical results of operations and financial
position of the Company. References in this Annual Report to "Zevia," the
"Company," "we," "us," and "our" refer (1) prior to the consummation of the
Reorganization Transactions, to Zevia LLC, and (2) after the consummation of the
Reorganization Transactions, to Zevia PBC and its consolidated subsidiaries
unless the context indicates otherwise. Our historical results are not
necessarily indicative of the results that may be expected for any period in the
future.

Overview

We are a high-growth company that develops, markets, sells, and distributes
great tasting, zero sugar beverages made with simple, plant-based ingredients.
We are a Delaware public benefit corporation and have been designated as a
"Certified B Corporation," and are focused on addressing the global health
challenges resulting from excess sugar consumption by offering a broad portfolio
of zero sugar, zero calorie, naturally sweetened beverages. All Zevia® beverages
are Non-GMO Project verified, gluten-free, Kosher, vegan and zero sodium and
include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers,
and Kidz drinks. Our products are distributed and sold principally across the
U.S. and Canada through a diverse network of major retailers in the food, drug,
warehouse club, mass, natural and e-commerce channels and in grocery and natural
product stores and specialty outlets. We believe that consumers increasingly
select beverage products based on taste, ingredients and fit with today's
consumer preferences, which has benefited the Zevia® brand and resulted in over
one billion cans of Zevia sold to date.

IPO and Reorganization Transactions



On July 26, 2021, we completed our IPO of Class A common stock, in which we sold
10,700,000 shares to the underwriters. Shares of Class A common stock began
trading on the New York Stock Exchange under the ticker symbol "ZVIA" on July
22, 2021. These shares were sold at an IPO price of $14.00 per share for net
proceeds of approximately $139.7 million, after deducting underwriting discounts
and commissions of $10.1 million. As of December 31, 2022, Zevia PBC holds an
economic interest of 68.7% in Zevia LLC and the remaining 31.3% represents the
non-controlling interest.

Factors Affecting the Comparability of Our Results of Operations



As a result of a number of factors, our historical results of operations are not
comparable from period to period and may not be comparable to our financial
results of operations in future periods. Set forth below is a brief discussion
of the key factors impacting the comparability of our results of operations.

Impact of the Reorganization Transactions



The Company is classified as a corporation for U.S. federal and state income tax
purposes. Our accounting predecessor, Zevia LLC, was and is a flow-through
entity for U.S. federal and most applicable state and local income tax purposes.
As an entity classified as a partnership for tax purposes, Zevia LLC is not
subject to U.S. federal and certain state and local income taxes. Any taxable
income or loss generated by Zevia LLC is passed through to its members,
including the Company. Zevia PBC is taxed as a C corporation and pays corporate
federal, state and local taxes with respect to income allocated from Zevia LLC
based on the Company's economic ownership interest in Zevia LLC, which was 68.7%
and 53.4% as of December 31, 2022 and 2021, respectively. Accordingly, the
historical results of operations and other financial information set forth in
this Annual Report do not include a provision for U.S. federal income taxes for
the periods prior to the IPO. Following the completion of the Reorganization
Transactions, the Company is taxed as a corporation and pays corporate federal,
state and local taxes with respect to income allocated from Zevia LLC based on
the Company's economic interest in Zevia LLC, which was 68.7% and 53.4%, as of
December 31, 2022 and 2021, respectively. Subsequent changes in economic
ownership in Zevia LLC of the Company can occur as Zevia LLC holders may convert
their shares of Class B common stock into an equivalent number of shares of
Class A common stock with income (loss) allocated to the Company based on the
economic interest applicable during each reporting period.

Zevia LLC is the predecessor of the Company for financial reporting purposes. As
a result, the consolidated financial statements of the Company recognize the
assets and liabilities received in the Reorganization Transactions at their
historical carrying amounts, as reflected in the historical consolidated
financial statements of Zevia LLC, the accounting predecessor.

In connection with the Reorganization Transactions and the IPO, we entered into
the TRA described in Note 17 - Income Taxes and Tax Receivable Agreement in the
Notes to our Consolidated Financial Statements included in Part II, Item 8 of
this Annual Report.

Initial Public Offering

In July 2021, the Company completed its IPO, which significantly impacted our
cash, debt, and equity balances. Concurrent with the IPO, the Company also
terminated its previous credit facility, which reduced our outstanding debt to
zero, and our interest expense was significantly reduced in the second half of
2021 and in 2022 relative to historical results.

                                       31
--------------------------------------------------------------------------------

Equity-Based Compensation



In March 2021, Zevia LLC modified certain outstanding RSU awards originally
granted in August 2020 to provide for vesting as follows: (i) in the event of a
change of control, the RSUs shall vest effective as of such change of control,
or (ii) in the event of an IPO, the RSUs shall vest in equal monthly
installments over a 36-month period following the termination of any lockup
period and shall be subject to the participant's continued employment through
such vesting date. In July 2021, Zevia modified all outstanding restricted
phantom unit awards to permit settlement into shares, eliminating the existing
cash-settlement provision. These modifications resulted in the revaluation of
the awards in accordance with generally accepted accounting principles in the
United States ("US GAAP"). No equity-based compensation had been recognized for
all of the RSUs and restricted phantom awards as the qualifying vesting event
(i.e., the IPO) was not probable. The Company recognized equity-based
compensation expense of $25.3 million and $77.4 million for the years-ended
December 31, 2022 and 2021, respectively, attributable to these RSUs and
restricted phantom unit awards, as well as other outstanding RSUs issued prior
to the IPO. As of December 31, 2022, the remaining unamortized fair value of the
RSU awards will be recognized as equity-based compensation over the remaining
service period of the awards which have a remaining vesting period of 25 months.
Refer to Note 12 - Equity-based Compensation in the Notes to our Consolidated
Financial Statements included in Part II, Item 8 of this Annual Report for
unamortized equity-based compensation costs related to each type of equity-based
incentive award.

Other Factors Affecting Our Performance

Macroeconomic Environment



The global economy, including the emergence of potential new variants of
COVID-19 and its resulting impacts on the global economy, including supply chain
challenges and labor shortages, have led to broad-based inflation in input
costs, logistics, manufacturing and labor costs. During the year ended December
31, 2022, we experienced supply chain constraints and a significant inflationary
impact compared to the prior year. These impacts have created headwinds for our
products that we expect to continue into 2023. These inflationary pressures have
and are expected to continue to impact our margins and operating results. We,
along with our competitors, have increased pricing on a number of products in
response to widespread inflation. These pricing increases may result in future
reductions in volume.

The following summarizes the components of our results of operations for the years ended December 31, 2022 and 2021, respectively.

Components of Our Results of Operations

Net Sales



We generate net sales from sales of our products, including Soda, Energy Drinks,
Organic Tea, Mixers, and Kidz drinks, to our customers, which include grocery
distributors, national retailers, natural products retailers, warehouse club and
e-commerce channels, in the U.S. and Canada.

We offer our customers sales incentives that are designed to support the
distribution of our products to consumers. These incentives include discounts,
trade promotions, price allowances and product placement fees. The amounts for
these incentives are deducted from gross sales to arrive at our net sales.

The following factors and trends in our business have driven net sales growth
over the past two years and are expected to continue to be key drivers of our
net sales growth for the foreseeable future:

leveraging our platform and mission to grow brand awareness, increase velocity and expand our consumer base;

continuing to grow our strong relationships across our retailer network and expand distribution amongst new and existing channels, both in-store and online; and

continuous innovation efforts, enhancement of existing products, and introduction of additional flavors within existing categories, as well as entering into new categories.

We expect both new distribution and increased organic sales from existing outlets and pricing strategies to contribute to our growth going forward, however sales levels in any given period may be impacted by seasonality and customers efforts to manage inventory.

We sell our products in the U.S. and Canada, direct to retailers and also through distributors. We do not have short- or long- term sales commitments with our customers.



Cost of Goods Sold

Cost of goods sold consists of all costs to acquire and manufacture our
products, including the cost of ingredients, raw materials, packaging, in-bound
freight and logistics and third-party production fees. Our cost of goods sold is
subject to price fluctuations in the marketplace, particularly in the price of
aluminum and other raw materials, as well as in the cost of production,
packaging, in-bound freight and logistics. Our results of operations depend on
our ability to arrange for the purchase of raw materials and the production of
our products in sufficient quantities at competitive prices. We have long-term
contracts with certain suppliers of stevia and aluminum cans. We expect over the
long term that, as the scale of our business increases, we will purchase a
greater percentage of our aluminum cans directly rather than through third-party
manufacturers. We have long-term contracts with certain manufacturers governing
pricing and other terms, but these contracts generally do not guarantee any
minimum production volumes on the part of the manufacturers.

We expect our cost of goods sold to increase in absolute dollars as our volume increases.



We elected to classify shipping and handling costs for salable product outside
of cost of goods sold, in selling and marketing expenses in our consolidated
statements of operations and comprehensive loss. As a result, our gross profit
and profit margin may not be comparable to other entities that present shipping
and handling costs as a component of cost of goods sold. During the year ended
December 31, 2022, the Company reclassified repackaging and handling costs from
cost of goods sold to selling and marketing expenses as a result of an
increasing trend in the occurrence of such fulfillment costs in the business.
The Company believes this classification change better portrays the financial
impacts of the fulfillment activities conducted by the Company. Refer to Note 2
- Summary of Significant Accounting Policies in the Notes to our Consolidated
Financial Statements included in Part II, Item 8 of this Annual Report for
amounts reclassified.
                                       32
--------------------------------------------------------------------------------

Gross Profit



Gross profit consists of our net sales less costs of goods sold. Our gross
profit and gross margin are affected by the mix of distribution channels of our
net sales in each period, as well as the level of discounts and promotions
offered during the period. Gross profit may be favorably impacted by leveraging
our asset-light business model and through increased distribution direct to
retailers, the increased scale of our business and our continued focus on cost
improvements, particularly in our supply chain.

Operating Expenses

Selling and Marketing Expenses



Selling and marketing expenses consist primarily of warehousing and distribution
costs and advertising and marketing expenses. Warehousing and distribution costs
include storage, transfer, repacking and handling fees and out-bound freight and
delivery charges. Advertising and marketing expenses consist of variable costs
associated with production and media buying of marketing programs and trade
events. Selling and marketing expenses also includes the incremental costs of
obtaining contracts, such as sales commissions.

Our selling and marketing expenses are expected to increase in absolute dollars,
both as a result of the increased warehousing and distribution costs resulting
from increased net sales, which we expect to be partially offset by our
continued focus on cost improvements in our supply chain, and as a result of
increased focus on marketing programs/spend.

General and Administrative Expenses



Administrative expenses include all salary and other personnel expenses (other
than equity-based compensation expense) for our employees, including employees
related to management, marketing, sales, product development, quality control,
accounting, information technology and other functions. Our general and
administrative expenses are expected to grow in absolute dollars but decline as
a percentage of net sales over time.

Equity-Based Compensation Expense



Equity-based compensation expense consists of the recorded expense of
equity-based compensation for our employees and for certain consultants and
service providers who are non-employees. We record equity-based compensation
expense for employee grants using grant date fair value for RSUs or a
Black-Scholes valuation model to calculate the fair value of stock options by
date granted. Equity-based compensation cost for RSU awards is measured based on
the closing fair market value of the Zevia LLC Class B unit or the Zevia PBC
Class A common stock, as applicable, on the date of grant. Over time, we expect
our equity-based compensation expense to significantly decrease compared to the
years ended December 31, 2022 and 2021, as a result of the expiration of the
lockup period in January 2022, which coincided with the end of the vesting
period for the majority of the awards granted pre-IPO, and the acceleration of
expense in 2022 in connection with the retirement of certain employees.

Depreciation and Amortization



Depreciation is primarily related to building and related improvements, computer
equipment, quality control and marketing equipment, and leasehold improvements.
Intangible assets subject to amortization consist of customer relationships and
software applications. Non-amortizable intangible assets consist of trademarks,
which represent the Company's exclusive ownership of the Zevia® brand used in
connection with the manufacturing, marketing, and distribution of its beverages.
We also own several other trademarks in both the U.S. and in foreign countries.
Depreciation and amortization expense is expected to increase in-line with
ongoing capital expenditures as our business grows.

Other income (expense), net

Other income (expense), net consists primarily of interest income (expense), and foreign currency (loss) gains.


                                       33
--------------------------------------------------------------------------------

Results of Operations

The following table sets forth selected items in our consolidated statements of operations and comprehensive loss for the periods presented:



                                                        Year Ended December 

31,


                                                        2022                

2021


(in thousands, except per share amounts)
Net sales                                          $      163,181       $     138,172
Cost of goods sold                                         93,160              74,231
Gross profit                                               70,021              63,941
Operating expenses:
Selling and marketing                                      52,869              45,130
General and administrative                                 36,793              27,516
Equity-based compensation                                  26,880              77,724
Depreciation and amortization                               1,347                 997
Total operating expenses                                  117,889             151,367
Loss from operations                                      (47,868 )           (87,426 )
Other income (expense), net                                   286                (207 )
Loss before income taxes                                  (47,582 )           (87,633 )
Provision for income taxes                                    (65 )               (34 )
Net loss and comprehensive loss                           (47,647 )           (87,667 )
Net loss attributable to Zevia LLC prior to the
Reorganization Transactions                                     -           

1,913


Loss attributable to noncontrolling interest               13,790           

39,768


Net loss attributable to Zevia PBC                 $      (33,857 )     $   

(45,986 )



Net loss per share attributable to common
stockholders
Basic                                              $        (0.81 )     $       (1.33 ) (1)
Diluted                                            $        (0.81 )     $       (1.33 ) (1)


(1) Represents earnings per share of Class A common stock and weighted-average
shares of Class A common stock outstanding for the period from July 22, 2021
through December 31, 2021, the period following the Reorganization Transactions
and IPO (see Note 16 of Notes to Consolidated Financial Statements)

The following table presents selected items in our consolidated statements of operations and comprehensive loss as a percentage of net sales for the respective periods presented. Percentages may not sum due to rounding:



                                                              Year Ended December 31,
                                                          2022                       2021
Net sales                                                        100 %                      100 %
Cost of goods sold                                                57 %                       54 %
Gross profit                                                      43 %                       46 %
Operating expenses:
Selling and marketing                                             32 %                       33 %
General and administrative                                        23 %                       20 %
Equity-based compensation                                         16 %                       56 %
Depreciation and amortization                                      1 %                        1 %
Total operating expenses                                          72 %                      110 %
Loss from operations                                             (29 )%                     (63 )%
Other income (expense), net                                        0 %                       (0 )%
Loss before income taxes                                         (29 )%                     (63 )%
Provision for income taxes                                        (0 )%                      (0 )
Net loss and comprehensive loss                                  (29 )%                     (63 )%
Net loss attributable to Zevia LLC prior to the
Reorganization Transactions                                        0 %                        1 %
Loss attributable to noncontrolling interest                       8 %                       29 %
Net loss attributable to Zevia PBC                               (21 )%                     (33 )%


Year Ended December 31, 2022 Compared to Year Ended December 31, 2021

Net Sales

                   Year Ended December 31,                 Change
(in thousands)       2022             2021         Amount      Percentage
Net sales        $    163,181       $ 138,172     $ 25,009            18.1 %



                                       34

--------------------------------------------------------------------------------


Net sales were $163.2 million for the year ended December 31, 2022 as compared
to $138.2 million for the year ended December 31, 2021. Equivalized cases sold
were 13.6 million for the year ended December 31, 2022 as compared to 12.3
million for the year ended December 31, 2021. Net sales growth was primarily
driven by the 10.7% increase in the number of equivalized cases sold, including
organic growth of $14.3 million, new distribution expansion of $6.3 million, and
pricing increases of $4.5 million. We define an equivalized case as a 288 fluid
ounce case.

Cost of Goods Sold

                       Year Ended December 31,                 Change
(in thousands)           2022             2021         Amount      Percentage
Cost of goods sold   $     93,160       $  74,231     $ 18,929            25.5 %


Cost of goods sold was $93.2 million for the year ended December 31, 2022 as
compared to $74.2 million for the year ended December 31, 2021. The increase of
$18.9 million, or 25.5%, was primarily due to higher costs due to broad-based
inflation resulting in $11.0 million in higher cost of goods sold, and a 10.7%
increase in the shipment of equivalized cases resulting in $7.9 million in
higher costs of goods sold.

Gross Profit and Gross Margin



                   Year Ended December 31,                 Change
(in thousands)       2022             2021        Amount       Percentage
Gross profit     $     70,021       $  63,941     $ 6,080              9.5 %
Gross margin             42.9 %          46.3 %


Gross profit was $70.0 million for the year ended December 31, 2022 as compared
to $63.9 million for the year ended December 31, 2021. The increase in gross
profit of $6.1 million, or 9.5%, was primarily driven by higher net sales,
partially offset by higher cost of goods sold.

Gross margin for the year ended December 31, 2022 declined to 42.9% from 46.3% in the prior-year period. The decline was primarily due to the impact of inflationary pressures partially offset by price increases.

Selling and Marketing Expenses



                                   Year Ended December 31,                

Change


(in thousands)                       2022             2021        Amount    

Percentage

Selling and marketing expenses $ 52,869 $ 45,130 $ 7,739

17.1 %




Selling and marketing expenses were $52.9 million for the year ended December
31, 2022 as compared to $45.1 million for the year ended December 31, 2021. The
increase of $7.7 million or 17.1%, was largely due to $3.0 million in higher
freight and warehousing costs as a result of increases in equivalized cases
produced and sold, higher repacking fees of $2.7 million, and higher freight and
warehousing costs of $3.0 million due to inflation. These increases were
partially offset by a reduction of non-working marketing costs of $1.5 million.

General and Administrative Expenses



                              Year Ended December 31,                         Change
(in thousands)               2022                 2021              Amount           Percentage
General and
administrative
expenses                $       36,793       $        27,516     $       9,277                33.7 %


General and administrative expenses were $36.8 million for the year ended
December 31, 2022 as compared to $27.5 million for the year ended December 31,
2021. The increase of $9.3 million, or 33.7%, was primarily driven by a $8.2
million increase in headcount and personnel costs to support our growth, and a
$1.3 million increase in costs related to being a public company, including
insurance, accounting and compliance, and legal and other professional fees.

Equity-Based Compensation Expense



                              Year Ended December 31,                 Change
(in thousands)                  2022             2021         Amount       Percentage
Equity-based compensation   $     26,880       $  77,724     $ (50,844 )          N/M


Equity-based compensation expense was $26.9 million for the year ended December
31, 2022, of which $3.1 million related to RSU awards and restricted phantom
stock awards that vested at the expiration of the IPO lock-up period in January
2022, $8.2 million related to RSU awards that were accelerated upon retirement
of certain senior management employees, and the remaining $15.6 million related
to outstanding equity-based awards being recognized over the remaining service
periods of the awards. Equity-based compensation expense was $77.7 million for
the year ended December 31, 2021, reflecting RSU awards and phantom stock awards
that generally vested over six months following the IPO.

Seasonality



Generally, we experience greater demand for our products during the second and
third fiscal quarters, which correspond to the warmer months of the year in our
major markets. As our business continues to grow, we expect to see continued
seasonality effects, with net sales tending to be greater in the second and
third quarters of the year.

                                       35
--------------------------------------------------------------------------------

                        Liquidity and Capital Resources

Liquidity and Capital Resources




As of December 31, 2022, we had $47.4 million in cash and cash equivalents. We
believe that our cash and cash equivalents as of December 31, 2022, together
with our operating activities and available borrowings under the Secured
Revolving Line of Credit, will provide adequate liquidity for ongoing
operations, planned capital expenditures and other investments beyond the next
12 months.

Our principal sources of liquidity are our existing cash and cash equivalents,
cash generated from sales of our products, and borrowing capacity currently
available under our Secured Revolving Line of Credit. Our primary cash needs are
for operating expenses, working capital and capital expenditures to support the
growth in our business.

Future capital requirements will depend on many factors, including our rate of
revenue growth, gross margin and the level of expenditures in all areas of the
Company. In future years, we may experience an increase in operating and capital
expenditures from time to time, as needed, as we expand business activities and
increase headcount to promote growth. To the extent that existing capital
resources and sales growth are not sufficient to fund future activities, we may
seek alternative financing through additional equity or debt financing
transactions. Additional funds may not be available on terms favorable to us or
at all. Also, we will continue to assess our liquidity needs in light of current
and future global health emergencies, inflationary pressures, the hostilities in
Eastern Europe, and political tensions between the U.S. and China that may
continue to disrupt and impact the global and national economies and global
financial markets. If the disruption continues into the future, we may not be
able to access the financial markets and could experience an inability to access
additional capital, which could negatively affect our operations in the future.
Failure to raise additional capital, if and when needed, could have a material
adverse effect on our financial position, results of operations, and cash flows.

Prior to our IPO, we had financed our operations through private sales of equity
securities and through sales of our products. In connection with our IPO, which
was completed on July 26, 2021, we sold an aggregate of 10,700,000 shares of our
Class A common stock at an IPO price of $14.00 per share and retained
approximately $90.1 million in net proceeds, after deducting underwriting
discounts and commissions and giving effect to the use of proceeds thereto. In
addition, we incurred $8.4 million of offering costs in connection with the IPO.
Upon consummation of the IPO, the Company became a holding company with no
operations of its own. Accordingly, the Company will be dependent on
distributions from Zevia LLC to pay its taxes, its obligations under the TRA and
other expenses. Any future credit facilities may impose limitations on the
ability of Zevia LLC to pay dividends to the Company.

In connection with the IPO and the Reorganization Transactions, the Direct Zevia
Stockholders and certain continuing members of Zevia LLC received the right to
receive future payments pursuant to the TRA. The amount payable under the TRA
will be based on an annual calculation of the reduction in our U.S. federal,
state and local taxes resulting from the utilization of certain pre-IPO tax
attributes and tax benefits resulting from sales and exchanges by continuing
members of Zevia LLC. See "Certain Relationships and Related Party
Transactions-Tax Receivable Agreement" included in the prospectus dated July 21,
2021 and filed with the SEC on July 23, 2021. We expect that the payments that
we may be required to make under the TRA may be substantial. Assuming no
material changes in the relevant tax law and that we earn sufficient taxable
income to realize all tax benefits that are subject to the TRA, we expect that
the reduction in tax payments for us associated with the federal, state and
local tax benefits described above would aggregate to approximately $65.7
million through 2037. Under such scenario we would be required to pay the Direct
Zevia Stockholders and certain continuing members of Zevia LLC 85% of such
amount, or $55.8 million through 2037.

The actual amounts may materially differ from these hypothetical amounts, as
potential future reductions in tax payments for us and TRA payments by us will
be calculated using prevailing tax rates applicable to us over the life of the
TRA and will be dependent on us generating sufficient future taxable income to
realize the benefit.

We cannot reasonably estimate future annual payments under the TRA given the
difficulty in determining those estimates as they are dependent on a number of
factors, including the extent of exchanges by continuing Zevia LLC unitholders,
the associated fair value of the underlying Zevia LLC units at the time of those
exchanges, the tax rates applicable, our future income, and the associated tax
benefits that might be realized that would trigger a TRA payment requirement.

However, a significant portion of any potential future payments under the TRA is
anticipated to be payable over 15 years, consistent with the period over which
the associated tax deductions would be realized by us, assuming Zevia LLC
generates sufficient income to utilize the deductions. If sufficient income is
not generated by Zevia LLC, the associated taxable income of Zevia will be
impacted and the associated tax benefits to be realized will be limited, thereby
similarly reducing the associated TRA payments to be made. Given the length of
time over which payments would be payable, the impact to liquidity in any single
year is greatly reduced.

Although the timing and extent of future payments could vary significantly under
the TRA for the factors discussed above, we anticipate funding payments from the
TRA from cash flows generated from operations.
                                       36
--------------------------------------------------------------------------------



Credit Facility

ABL Credit Facility

On February 22, 2022, we obtained a revolving credit facility (the "Secured
Revolving Line of Credit") by entering into a Loan and Security Agreement with
Bank of America, N.A. Under the Secured Revolving Line of Credit, we may draw
funds up to an amount not to exceed the lesser of (i) a $20 million revolving
commitment and (ii) a borrowing base which is comprised of inventory and
receivables. Up to $2 million of the Secured Revolving Line of Credit may be
used for letter of credit issuances with the option to increase the commitment
under the Secured Revolving Line of Credit by up to $10 million, subject to
certain conditions. The Secured Revolving Line of Credit matures on February 22,
2027. There have been no amounts drawn from the Secured Revolving Line of
Credit. The Secured Revolving Line of Credit is secured by a first priority
security interest in substantially all of the Company's assets.

Loans under the Secured Revolving Line of Credit bear interest based on either,
at our option, the Bloomberg Short-Term Bank Yield Index rate plus an applicable
margin between 1.50% to 2.00% or the Base Rate (customarily defined) plus an
applicable margin between 0.50% to 1.00% with margin, in each case, determined
by the average daily availability under the Secured Revolving Line of Credit.

We are required under the Secured Revolving Line of Credit to comply with
certain covenants, including, among others, by maintaining Liquidity (as defined
therein) of $7 million at all times until December 31, 2023. Thereafter, we must
satisfy a financial covenant requiring a minimum fixed charge coverage ratio of
1.00 to 1.00 as of the last day of any fiscal quarter following the occurrence
of certain events of default that are continuing or any day on which
availability under the Secured Revolving Line of Credit is less than the greater
of $3 million and 17.5% of the borrowing base, and must again satisfy such
financial covenant as of the last day of each fiscal quarter thereafter until
such time as there are no events of default and availability has been above such
threshold for 30 consecutive days. As of December 31, 2022, the Company was in
compliance with its liquidity covenant.

Cash Flows

The following table presents the major components of net cash flows from and used in operating, investing and financing activities for the periods indicated.



                                 Twelve Months Ended December 31,
(in thousands)                      2022                   2021

Cash (used in) provided by: Operating activities $ (20,778 ) $ (17,806 ) Investing activities $ 27,407 $ (33,143 ) Financing activities $ (2,340 ) $ 79,123

Net Cash Used in Operating Activities

Our cash flows used in operating activities are primarily influenced by working capital requirements.



Net cash used in operating activities of $20.8 million for the year ended
December 31, 2022 was primarily driven by a net loss of $47.6 million and by a
net decrease in cash related to changes in operating assets and liabilities of
$2.1 million, partially offset by non-cash expenses of $28.9 million primarily
related to equity-based compensation and depreciation and amortization expense.
Changes in cash flows related to operating assets and liabilities were primarily
due to an increase in accounts receivable of $2.0 million due to increases in
net sales and a decrease in accounts payable and accrued expenses and other
current liabilities of $4.1 million, primarily due to timing of inventory
purchases, partially offset by decrease in inventories of $3.9 million due to
timing of inventory purchases and a $0.8 million decrease in prepaid expenses
and other assets, primarily insurance expenses as a result of becoming a public
company.

Net cash used in operating activities of $17.8 million for the year ended
December 31, 2021 was primarily driven by a net loss of $87.7 million and by a
net decrease in cash related to changes in operating assets and liabilities of
$9.5 million, partially offset by non-cash expenses of $79.4 million primarily
related to equity-based compensation. Changes in cash flows related to operating
assets and liabilities primarily consisted of a $10.7 million increase in
anticipation of future sales, a $2.1 million increase in accounts receivable due
to increase in net sales, and a $2.5 million increase in prepaid expenses and
other assets, primarily insurance expenses as a result of becoming a public
company, partially offset by a $6.4 million increase in accounts payable,
accrued expenses and other current liabilities due to our overall growth.

Net Cash Provided by (Used in) Investing Activities



Net cash provided by investing activities of $27.4 million for the year ended
December 31, 2022 was primarily due to proceeds from maturities of short-term
investments of $30.0 million, offset by capital expenditures of $2.6 million for
the purchase of marketing fixtures, software applications and computer equipment
used in ongoing operations.

Net cash used in investing activities of $33.1 million for the year ended December 31, 2021 was primarily due to payments for purchases of short-term investments of $30.0 million and capital expenditures of $3.1 million, of which $1.7 million was invested in a warehouse facility and the remaining capital expenditures were for software applications and computer equipment used in ongoing operations.

Net Cash (Used in) Provided by Financing Activities



Net cash used in financing activities of $2.3 million for the year ended
December 31, 2022 was primarily due to minimum tax withholdings paid on behalf
of employees for net share settlements of $2.1 million and payment of debt
issuance costs of $0.3 million in connection with the Secured Revolving Line of
Credit.

Net cash provided by financing activities of $79.1 million for the year ended
December 31, 2021 was due to our IPO of Class A common stock, in which received
net proceeds of $139.7 million, after deducting underwriting discounts and
commissions of $10.1 million. We paid offering expenses related to the IPO and
the Reorganization of $8.1 million. Upon the closing of the IPO, we used (i)
approximately $25.5 million to purchase Class B units and
                                       37
--------------------------------------------------------------------------------


corresponding shares of Class B common stock from certain Zevia LLC's
unitholders, including certain members of our senior management, at a per-unit
price equal to the per-share price paid by the underwriters for shares of Class
A common stock, (ii) approximately $0.4 million to cancel and cash-out
outstanding options held by certain option holders, including certain members of
our senior management, at a per-option price equal to the per-share price paid
by the underwriters for shares of Class A common stock, and (iii) approximately
$23.7 million to pay the cash consideration to certain pre-IPO institutional
investors in connection with the merger of the blocker corporations into Zevia
PBC with Zevia PBC surviving. The IPO related amounts were partially offset by
distribution to unitholders for tax payments of $2.7 million.

Non-GAAP Financial Measures



We report our financial results in accordance with US GAAP. However, management
believes that Adjusted EBITDA, a non-GAAP financial measure, provides investors
with additional useful information in evaluating our operating performance.

We calculate Adjusted EBITDA as net loss adjusted to exclude: (1) other income
(expense), net, which includes interest (income) expense, foreign currency
(gains) losses, and (gains) losses on disposal of fixed assets, (2) provision
(benefit) for income taxes, (3) depreciation and amortization, and (4)
equity-based compensation. Adjusted EBITDA may in the future also be adjusted
for amounts impacting net income related to the TRA liability and other
infrequent and unusual transactions.

Adjusted EBITDA is a financial measure that is not required by, or presented in
accordance with US GAAP. We believe that Adjusted EBITDA, when taken together
with our financial results presented in accordance with US GAAP, provides
meaningful supplemental information regarding our operating performance and
facilitates internal comparisons of our historical operating performance on a
more consistent basis by excluding certain items that may not be indicative of
our business, results of operations or outlook. In particular, we believe that
the use of Adjusted EBITDA is helpful to our investors as it is a measure used
by management in assessing the health of our business, determining incentive
compensation and evaluating our operating performance, as well as for internal
planning and forecasting purposes.

Adjusted EBITDA is presented for supplemental informational purposes only, has
limitations as an analytical tool and should not be considered in isolation or
as a substitute for financial information presented in accordance with US GAAP.
Some of the limitations of Adjusted EBITDA include that (1) it does not properly
reflect capital commitments to be paid in the future, (2) although depreciation
and amortization are non-cash charges, the underlying assets may need to be
replaced and Adjusted EBITDA does not reflect these capital expenditures, (3) it
does not consider the impact of equity-based compensation expense, including the
potential dilutive impact thereof, and (4) it does not reflect other
non-operating expenses, including interest (income) expense, foreign currency
(gains)/losses and (gains)/losses on disposal of fixed assets. In addition, our
use of Adjusted EBITDA may not be comparable to similarly-titled measures of
other companies because they may not calculate Adjusted EBITDA in the same
manner, limiting its usefulness as a comparative measure. Because of these
limitations, when evaluating our performance, you should consider Adjusted
EBITDA alongside other financial measures, including our net income (loss) and
other results stated in accordance with US GAAP.

The following table presents a reconciliation of net loss, the most directly comparable financial measure stated in accordance with US GAAP, to Adjusted EBITDA for the periods presented:



                                    Year Ended December 31,
(in thousands)                        2022             2021
Net loss and comprehensive loss   $    (47,647 )     $ (87,667 )
Other (income) expense, net*              (286 )           207
Provision for income taxes                  65              34
Depreciation and amortization            1,347             997
Equity-based compensation               26,880          77,724
Adjusted EBITDA                   $    (19,641 )     $  (8,705 )

* Includes interest (income) expense, foreign currency (gains) losses, and (gains) losses on disposal of fixed assets.

Commitments



Effective March 2022, the Company entered into an amendment to the lease for our
corporate headquarters offices to extend the term through December 31, 2023 and
expand the total square footage from 17,923 square feet to 20,185 square feet
commencing on May 1, 2022. In January 2023, the Company extended the lease term
through December 31, 2026.

The following table summarizes our significant contractual obligations as of
December 31, 2022:

                                                             Payments Due by Period
                                              Less Than One                                         More Than Five
                                 Total        Year              1-3 Years         3-5 Years             Years
                                                                 (in thousands)
Rent obligations (1)           $      745     $         745     $           -     $           -     $            -
Total                          $      745     $         745     $           -     $           -     $            -

(1) Real estate lease payments

Our inventory purchase commitments are generally short-term in nature and have ordinary commercial terms. We did not have any material long-term inventory purchase commitments as of December 31, 2022.



Our leases generally consist of long-term operating leases, which are payable
monthly and relate to our office space. For a further discussion on our debt and
operating lease commitments as of December 31, 2022, see the sections above as
well as Note 7 - Debt, and Note 8 - Leases, in the Notes to our Consolidated
Financial Statements included in Part II, Item 8 of this Annual Report.

We expect to satisfy these commitments through a combination of cash on hand and cash generated from sales of our products.


                                       38
--------------------------------------------------------------------------------

Critical Accounting Policies and Estimates



Our consolidated financial statements and the related notes thereto included
elsewhere in this Annual Report on Form 10-K are prepared in accordance with US
GAAP. The preparation of financial statements requires us to make estimates and
assumptions that affect the reported amounts of assets, liabilities, sales,
costs and expenses and related disclosures. We base our estimates on historical
experience and on various other assumptions that we believe to be reasonable
under the circumstances. Actual results could differ significantly from our
estimates. To the extent that there are differences between our estimates and
actual results, our future financial statement presentation, financial
condition, results of operations and cash flows will be affected.

Critical accounting estimates are those that we consider the most important to
the portrayal of our financial condition and operating results because they
require our most difficult, subjective or complex judgments, often as a result
of the need to make estimates about the effect of matters that are inherently
uncertain. See Note 2. Summary of Significant Accounting Policies, in the Notes
to our Consolidated Financial Statements included in Part II, Item 8 of this
Annual Report, for information about these policies as well as a description of
our other accounting policies. Our critical accounting estimates are described
below.

Revenue Recognition

We recognize revenue when performance obligations under the terms of a contract
with the customer are satisfied. Accruals for customer incentives and
allowances, sales returns and marketing programs are established for the
expected payout based on contractual terms, volume-based metrics and/or
historical trends. These incentives and discounts include cash discounts, price
allowances, volume-based rebates, product placement fees and certain other
financial support for items such as trade promotions, displays, new products,
consumer incentives and advertising assistance.

Our customer incentives and allowances contain uncertainties because it requires
management to make assumptions and to apply judgment regarding our contractual
terms in order to estimate our customer participation and volume performance
levels which impact the revenue recognition. Our estimates are based primarily
on a combination of known or historical transaction experiences. Differences
between estimated expenses and actual costs are normally insignificant and are
recognized to earnings in the period differences are determined.

Additionally, judgment is required to ensure the classification of the spend is
correctly recorded as either a reduction from gross sales or advertising and
marketing expense, which is a component of our selling and marketing expenses.

A 10% change in the accrual for customer incentives and allowances would have
affected our income from operations by $0.6 million and $0.4 million for the
years ended December 31, 2022 and 2021, respectively.

Inventories



Inventories consist of raw materials and finished goods. Raw materials include
costs for the Company's ingredients and packaging inventories. The costs of
finished goods inventories include production fees from third-party
manufacturers. Inventories are stated at the lower of average cost or net
realizable value. The Company regularly reviews whether the net realizable value
of its inventory is lower than its carrying value. Indicators that could result
in inventory write downs include age of inventory, damaged inventory, slow
moving products, and products at the end of their life cycles. While management
believes that inventory is appropriately stated at the lower of average cost or
net realizable value, judgment is involved in determining the net realizable
value of inventory. The lower of average cost or net realizable value
adjustments were not material at December 31, 2022 or December 31, 2021.

We periodically write-down our inventory to the lower of cost and net realizable
value based on our estimates that consider historical usage, future demand, and
inventory production date. These factors are impacted by market and economic
conditions and changes in strategic direction. The calculation of our inventory
valuation, specifically the write-down for excess or obsolete inventories,
requires management to make assumptions and to apply judgment regarding
forecasted customer demand that may turn out to be inaccurate. Inventory
valuation reserves, once established, are not reversed until the related
inventory has been sold or scrapped. Inventory valuation reserves were $0.4
million as of December 31, 2022 and 2021.

Income Taxes



The Company is the managing member of Zevia LLC and, as a result, consolidates
the financial results of Zevia LLC in the consolidated financial statements.
Zevia LLC is a pass-through entity for U.S. federal and most applicable state
and local income tax purposes. As an entity classified as a partnership for tax
purposes, Zevia LLC is not subject to U.S. federal and certain state and local
income taxes. Any taxable income or loss generated by Zevia LLC is passed
through to its members, including the Company. The Company is taxed as a
corporation and pays corporate federal, state and local taxes with respect to
income allocated from Zevia LLC based on the Company's economic interest in
Zevia LLC, which was 68.7% and 53.4% as of December 31, 2022 and 2021,
respectively. Subsequent changes in economic ownership in Zevia LLC of the
Company can occur as Zevia LLC holders may convert their shares of Class B
common stock into an equivalent number of shares of Class A common stock with
income (loss) allocated to the Company based on the economic interest applicable
during each reporting period.

The Company accounts for income taxes under the asset and liability method,
which requires the recognition of deferred tax assets and liabilities ("DTAs"
and "DTLs") for the expected future tax consequences of events that have been
included in the financial statements. Under this method, we determine DTAs and
DTLs on the basis of the differences between the financial statement and tax
bases of assets and liabilities by using enacted tax rates in effect for the
year in which the differences are expected to reverse. The effect of a change in
tax rates on DTAs and DTLs is recognized in income in the period that includes
the enactment date.

We record a valuation allowance to reduce deferred tax assets to the amount that
we believe is more likely than not to be realized. In assessing the need for a
valuation allowance, we consider all positive and negative evidence, including
scheduled reversals of deferred tax liabilities, historical levels of income,
projections of future income, expectations and risk associated with estimates of
future taxable income and ongoing prudent and practical tax planning strategies.
To the extent that we believe it is more likely than not that some portion of
our deferred tax assets will not be realized, we would increase the valuation
allowance against deferred tax assets. The determination of recording or
releasing a tax valuation allowance is made, in part, pursuant to an assessment
performed by management regarding the likelihood that we will generate
sufficient future taxable income against which the benefits of our deferred tax
assets may or may not be realized. This assessment requires management to
exercise significant judgment and make estimates with respect to our ability to
generate revenue, gross profits, operating income and taxable income in future
periods. Although we believe that
                                       39
--------------------------------------------------------------------------------


the judgment we used is reasonable, actual results can differ due to a change in
market conditions, changes in tax laws and other factors. As of December 31,
2022, we have a full valuation allowance against deferred tax assets totaling
$72.7 million.

In accordance with ASC 740, Income Taxes we perform a comprehensive review of
uncertain tax positions regularly. The guidance prescribes a recognition
threshold and measurement attribute for the financial statement recognition and
measurement of a tax position taken, or expected to be taken, in a tax return.
We determine the tax liability for uncertain tax positions based on a two-step
process. The first step is to determine whether it is more likely than not based
on technical merits that each income tax position would be sustained upon
examination. The second step is to measure the tax benefit as the largest amount
that has a greater than 50% likelihood of being realized upon ultimate
settlement with a tax authority that has full knowledge of all relevant
information. The assessment of each tax position requires significant judgment
and estimates. All tax positions are periodically analyzed and adjusted as a
result of events, such as the resolution of tax audits, issuance of new
regulations or new case law, negotiations with tax authorities, and expiration
of statutes of limitations. We did not record any unrecognized tax benefit as of
December 31, 2022. We recognize both accrued interest and penalties, when
appropriate, in income taxes in the accompanying consolidated statements of
operations and comprehensive loss.

Tax Receivable Agreement



The Company expects to obtain an increase in its share of tax basis in the net
assets of Zevia, LLC when Class B units are exchanged by the holders of Class B
units for shares of Class A common stock of the Company and upon certain
qualifying transactions. Each change in outstanding shares of Class A common
stock of the Company results in a corresponding change in the Company's
ownership of Class A units of Zevia, LLC. The Company intends to treat any
exchanges of Class B units as direct purchases of LLC interests for U.S. federal
income tax purposes. These increases in tax basis may reduce the amounts that
Zevia PBC would otherwise pay in the future to various taxing authorities. They
may also decrease gains (or increase losses) on future dispositions of certain
capital assets to the extent tax basis is allocated to those capital assets.

In connection with the IPO, the Company entered into a TRA with continuing
members of Zevia LLC and the Direct Zevia Stockholders. In the event that such
parties exchange any or all of their Class B units for Class A common stock, the
TRA requires the Company to make payments to such holders for 85% of the tax
benefits realized, or in some cases deemed to be realized, by the Company by
such exchange as a result of (i) certain favorable tax attributes acquired from
the Blocker Companies in the Mergers (including net operating losses and the
Blocker Companies' allocable share of existing tax basis), (ii) increases in tax
basis resulting from Zevia PBC's acquisition of continuing member's Zevia LLC
units in connection with the IPO and in future exchanges and, (iii) tax basis
increases attributable to payments made under the TRA (including tax benefits
related to imputed interest). The annual tax benefits are computed by
calculating the income taxes due, including such tax benefits, and the income
taxes due without such benefits. The Company expects to benefit from the
remaining 15% of any tax benefits that it may actually realize. The TRA payments
are not conditioned upon any continued ownership interest in Zevia, LLC or the
Company. To the extent that the Company is unable to timely make payments under
the TRA for any reason, such payments generally will be deferred and will accrue
interest until paid.

The timing and amount of aggregate payments due under the TRA may vary based on
a number of factors, including the amount and timing of the taxable income the
Company generates each year and the tax rate then applicable. The Company
calculates the liability under the TRA using a complex TRA model, which includes
an assumption related to the fair market value of assets. Payments are generally
due under the TRA within a specified period of time following the filing of the
Company's tax return for the taxable year with respect to which the payment
obligation arises, although interest on such payments will begin to accrue at a
rate of the Secured Overnight Financing Rate ("SOFR") plus 300 basis points from
the due date (without extensions) of such tax return.

The amount of existing tax basis and the anticipated tax basis adjustments will
vary depending upon a number of factors, including our blended federal and state
tax rate and the amount and timing of our income, the increase in the Zevia's
allocable share of existing tax basis and the tax basis adjustment of the
tangible and intangible assets of the Company upon the exchange of Zevia LLC
units for shares of Class A common stock, and our possible utilization of
certain tax attributes. As a result, payments that Zevia PBC may make under the
TRA could be substantial.

The TRA provides that if (i) certain mergers, asset sales, other forms of
business combinations, or other changes of control were to occur; (ii) there is
a material uncured breach of any obligations under the TRA; or (iii) the Company
elects an early termination of the TRA, then the TRA will terminate and the
Company's obligations, or the Company's successor's obligations, under the TRA
will accelerate and become due and payable, based on certain assumptions,
including an assumption that the Company would have sufficient taxable income to
fully utilize all potential future tax benefits that are subject to the TRA and
that any Class B units that have not been exchanged are deemed exchanged for the
fair market value of the Company's Class A common stock at the time of
termination.

As of December 31, 2022, the Company has concluded, based on applicable
accounting standards, that it was more likely than not that its deferred tax
assets subject to the TRA would not be realized; therefore, the Company has not
recorded a liability related to the tax savings it may realize from utilization
of such deferred tax assets. The TRA liability that would be recognized if the
associated tax benefits were determined to be fully realizable totaled $55.8
million at December 31, 2022. If utilization of the deferred tax asset subject
to the TRA becomes more likely than not in the future, the Company will record a
liability related to the TRA which will be recognized as expense within its
consolidated statements of operations.

Recent Accounting Pronouncements

Refer to Note 2 - Summary of Significant Accounting Policies in the Notes to our Consolidated Financial Statements included in this Annual Report for a discussion of recently issued accounting pronouncements not yet adopted.

Emerging Growth Company Status



We are an "emerging growth company," as defined in the JOBS Act, and we may take
advantage of certain exemptions from various reporting requirements that are
applicable to other public companies that are not "emerging growth companies."
We may take advantage of these exemptions until we are no longer an "emerging
growth company." Section 107 of the JOBS Act provides that an "emerging growth
company" can take advantage of the extended transition period afforded by the
JOBS Act for the implementation of new or revised accounting standards. We have
elected to use the extended transition period for complying with new or revised
accounting standards and as a result of this election, our financial statements
may not be comparable to companies that comply with public company effective
dates. We may take advantage of these exemptions up until the last day of the
fiscal year following the fifth anniversary of the IPO or such earlier time that
we are no longer an emerging growth company. We would cease to be an emerging
growth company if any of the following events occur; (i) we have more than
$1.235 billion in annual revenue, (ii) we have more than $700.0
                                       40

--------------------------------------------------------------------------------




million in market value of our Class A common stock held by non-affiliates (and
we have been a public company for at least 12 months and have filed one annual
report on Form 10-K) or (iii) we issue more than $1.0 billion of non-convertible
debt securities over a three-year period.

© Edgar Online, source Glimpses